1887

Chapter 5 : Adenoviral Infections in Transplant Recipients

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Adenoviral Infections in Transplant Recipients, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815592/9781555814441_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555815592/9781555814441_Chap05-2.gif

Abstract:

Adenovirus (ADV) was first associated with severe morbidity and mortality in bone marrow transplant recipients in 1985. Numerous reports since then have confirmed the importance of ADV in recipients of hematopoietic stem cell transplants (HSCT). The immunosuppression involved with solid organ transplantation (SOT) also predisposes recipients to severe initial or reactivation ADV infections. This chapter describes the emerging importance of ADV in both HSCT and SOT recipients. A retrospective review of pediatric liver transplant recipients noted infection in 10%, with evidence of invasive disease occurring in 4.1%; most disease occurred in the immediate posttransplant period. Nuclear enlargement and intranuclear inclusions develop and contain adenovirions as seen by electron microscopy. Immunohistochemistry and in situ hybridization (technically challenging and not widely available) may further improve the sensitivity over that of histopathology and may be particularly helpful in differentiating rejection from ADV disease, particularly among small bowel transplant recipients. Treatment of ADV in HSCT and SOT recipients can be broken down into two major issues: whom to treat and how best to treat them. A wide variety of antiviral drugs have been used to treat ADV disease. Vidarabine has limited availability and significant toxicity but may have a role in the management of hemorrhagic cystitis. At present, only cidofovir appears to have significant antiviral efficacy. Future treatment strategies might include analogs of cidofovir and ex vivo generation of ADV-specific cytotoxic T cells with subsequent transplantation into patients suffering from or at high risk for ADV disease.

Citation: Anderson E, Ison M. 2008. Adenoviral Infections in Transplant Recipients, p 75-91. In Scheld W, Hammer S, Hughes J (ed), Emerging Infections 8. ASM Press, Washington, DC. doi: 10.1128/9781555815592.ch5

Key Concept Ranking

Central Nervous System Diseases
0.5663762
0.5663762
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815592.ch05
1. Anderson, E. J.,, J. A. Guzman-Cottrill,, M. Kletzel,, K. Thormann,, C. Sullivan,, X. Zheng,, and B. Z. Katz. 2008. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr. Transplant. 12:219227.
2. August, M. J.,, and A. L. Warford. 1987. Evaluation of a commercial monoclonal antibody for detection of adenovirus antigen. J. Clin. Microbiol. 25:22332235.
3. Avivi, I.,, S. Chakrabarti,, D. W. Milligan,, H. Waldmann,, G. Hale,, H. Osman,, K. N. Ward,, C. D. Fegan,, K. Yong,, A. H. Goldstone,, D. C. Linch,, and S. Mackinnon. 2004. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol. Blood Marrow Transplant. 10:186194.
4. Baldwin, A.,, H. Kingman,, M. Darville,, A. B. Foot,, D. Grier,, J. M. Cornish,, N. Goulden,, A. Oakhill,, D. H. Pamphilon,, C. G. Steward,, and D. I. Marks. 2000. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 26:13331338.
5. Berho, M.,, M. Torroella,, A. Viciana,, D. Weppler,, J. Thompson,, J. Nery,, A. Tzakis,, and P. Ruiz. 1998. Adenovirus enterocolitis in human small bowel transplants. Pediatr. Transplant. 2:277282.
6. Blanke, C.,, C. Clark,, E. R. Broun,, G. Tricot,, I. Cunningham,, K. Cornetta,, A. Hedderman,, and R. Hromas. 1995. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am. J. Med. 99:326328.
7. Bordigoni, P.,, A. S. Carret,, V. Venard,, F. Witz,, and A. Le Faou. 2001. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 32:12901297.
8. Briassoulis, G.,, G. Papadopoulos,, N. Zavras,, V. Pailopoulos,, T. Hatzis,, and V. Thanopoulos. 2000. Cardiac troponin I in fulminant adenovirus myocarditis treated with a 24-hour infusion of high-dose intravenous immunoglobulin. Pediatr. Cardiol. 21:391394.
9. Bridges, N. D.,, T. L. Spray,, M. H. Collins,, N. E. Bowles,, and J. A. Towbin. 1998. Adenovirus infection in the lung results in graft failure after lung transplantation. J. Thorac. Cardiovasc. Surg. 116:617623.
10. Bruno, B.,, T. Gooley,, R. C. Hackman,, C. Davis,, L. Corey,, and M. Boeckh. 2003. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol. Blood Marrow Transplant. 9:341352.
11. Cassano, W. F. 1991. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 7:247248.
12. Centers for Disease Control and Prevention. 2007. Acute respiratory disease associated with adenovirus serotype 14—four states, 2006–2007. Morb. Mortal. Wkly. Rep. 56:11811184.
13. Chakrabarti, S.,, K. E. Collingham,, C. D. Fegan,, and D. W. Milligan. 1999. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant. 23:12091211.
14. Chakrabarti, S.,, K. E. Collingham,, C. D. Fegan,, D. Pillay,, and D. W. Milligan. 2000. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant. 26:305307.
15. Chakrabarti, S.,, V. Mautner,, H. Osman,, K. E. Collingham,, C. D. Fegan,, P. E. Klapper,, P. A. Moss,, and D. W. Milligan. 2002. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:16191627.
16. Chakrabarti, S.,, D. W. Milligan,, P. A. Moss,, and V. Mautner. 2004. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk. Lymphoma 45:873885.
17. Chen, F. E.,, R. H. Liang,, J. Y. Lo,, K. Y. Yuen,, T. K. Chan,, and M. Peiris. 1997. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant. 20:997999.
18. Claas, E. C.,, M. W. Schilham,, C. S. de Brouwer,, P. Hubacek,, M. Echavarria,, A. C. Lankester,, M. J. van Tol,, and A. C. Kroes. 2005. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J. Clin. Microbiol. 43:17381744.
19. Davis, D.,, P. J. Henslee,, and W. R. Markesbery. 1988. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann. Neurol. 23:385389.
20. de Oliveira, C. B.,, D. Stevenson,, L. LaBree,, P. J. McDonnell,, and M. D. Trousdale. 1996. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antivir. Res. 31:165172.
21. Donoso Mantke, O.,, R. Meyer,, S. Prosch,, A. Nitsche,, K. Leitmeyer,, R. Kallies,, and M. Niedrig. 2005. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients’ pool. J. Heart Lung Transplant. 24:16321638.
22. Duggan, J. M.,, J. Farrehi,, S. Duderstadt,, N. J. Turner,, and R. Fekety. 1997. Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. Am. J. Med. 103:439440.
23. Ebner, K.,, M. Suda,, F. Watzinger,, and T. Lion. 2005. Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J. Clin. Microbiol. 43:30493053.
24. Echavarria, M.,, M. Forman,, M. J. van Tol,, J. M. Vossen,, P. Charache,, and A. C. Kroes. 2001. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 358:384385.
25. Erard, V.,, M. L. Huang,, J. Ferrenberg,, L. Nguy,, T. L. Stevens-Ayers,, R. C. Hackman,, L. Corey,, and M. Boeckh. 2007. Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin. Infect. Dis. 45:958965.
26. Espy, M. J.,, J. C. Hierholzer,, and T. F. Smith. 1987. The effect of centrifugation on the rapid detection of adenovirus in shell vials. Am. J. Clin. Pathol. 88:358360.
27. Feuchtinger, T.,, S. Matthes-Martin,, C. Richard,, T. Lion,, M. Fuhrer,, K. Hamprecht,, R. Hand-gretinger,, C. Peters,, F. R. Schuster,, R. Beck,, M. Schumm,, R. Lotfi,, G. Jahn,, and P. Lang. 2006. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 134:6476.
28. Flomenberg, P.,, J. Babbitt,, W. R. Drobyski,, R. C. Ash,, D. R. Carrigan,, G. V. Sedmak,, T. McAuliffe,, B. Camitta,, M. M. Horowitz,, N. Bunin, et al. 1994. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169:775781.
29. Gavin, P. J.,, and B. Z. Katz. 2002. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110:e9.
30. Gray, G. C.,, T. McCarthy,, M. G. Lebeck,, D. P. Schnurr,, K. L. Russell,, A. E. Kajon,, M. L. Landry,, D. S. Leland,, G. A. Storch,, C. C. Ginocchio,, C. C. Robinson,, G. J. Demmler,, M. A. Saubolle,, S. C. Kehl,, R. Selvarangan,, M. B. Miller,, J. D. Chappell,, D. M. Zerr,, D. L. Kiska,, D. C. Halstead,, A. W. Capuano,, S. F. Setterquist,, M. L. Chorazy,, J. D. Dawson,, and D. D. Erdman. 2007. Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004–2006. Clin. Infect. Dis. 45:11201131.
31. Hale, G. A.,, H. E. Heslop,, R. A. Krance,, M. A. Brenner,, D. Jayawardene,, D. K. Srivastava,, and C. C. Patrick. 1999. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 23:277282.
32. Hartline, C. B.,, K. M. Gustin,, W. B. Wan,, S. L. Ciesla,, J. R. Beadle,, K. Y. Hostetler,, and E. R. Kern. 2005. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J. Infect. Dis. 191:396399.
33. Hayden, F. G. 2001. Cidofovir, p. 1321–1322. In J. G. Hardman,, L. E. Limbird, and, A. G. Gilman (ed.), Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. McGraw-Hill, New York, NY.
34. Heemskerk, B.,, A. C. Lankester,, T. van Vreeswijk,, M. F. Beersma,, E. C. Claas,, L. A. Veltrop-Duits,, A. C. Kroes,, J. M. Vossen,, M. W. Schilham,, and M. J. van Tol. 2005. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis. 191:520530.
35. Heim, A.,, C. Ebnet,, G. Harste,, and P. Pring-Akerblom. 2003. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70:228239.
36. Hierholzer, J. C. 1992. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5:262274.
37. Hierholzer, J. C.,, K. H. Johansson,, L. J. Anderson,, C. J. Tsou,, and P. E. Halonen. 1987. Comparison of monoclonal time-resolved fluoroimmunoassay with monoclonal capture-biotinylated detector enzyme immunoassay for adenovirus antigen detection. J. Clin. Microbiol. 25:16621667.
38. Ho, E. S.,, D. C. Lin,, D. B. Mendel,, and T. Cihlar. 2000. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11:383393.
39. Hoffman, J. A.,, A. J. Shah,, L. A. Ross,, and N. Kapoor. 2001. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7:388394.
40. Howard, D. S.,, I. G. Phillips,, D. E. Reece,, R. K. Munn,, J. Henslee-Downey,, M. Pittard,, M. Barker,, and C. Pomeroy. 1999. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 29:14941501.
41. Hromas, R.,, C. Clark,, C. Blanke,, G. Tricot,, K. Cornetta,, A. Hedderman,, and E. R. Broun. 1994. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant. 14:663664.
42. Hromas, R.,, K. Cornetta,, E. Srour,, C. Blanke,, and E. R. Broun. 1994. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84:16891690.
43. Humar, A.,, K. Doucette,, D. Kumar,, X. L. Pang,, D. Lien,, K. Jackson,, and J. Preiksaitis. 2006. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J. Heart Lung Transplant. 25:14411446.
44. Humar, A.,, D. Kumar,, T. Mazzulli,, R. R. Razonable,, G. Moussa,, C. V. Paya,, E. Covington,, E. Alecock,, and M. D. Pescovitz. 2005. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am. J. Transplant. 5:25552559.
45. Ishida, H.,, N. Shin-Nakai,, T. Yoshihara,, T. Teramura,, T. Imamura,, A. Mukouyama,, A. Morimoto,, and S. Imashuku. 2005. Invasive adenoviral infection in a recipient of unrelated bone marrow transplantation: problems with diagnostic PCR. Pediatr. Blood Cancer 44:416419.
46. Ison, M. G. 2006. Adenovirus infections in transplant recipients. Clin. Infect. Dis. 43:331339.
47. Ison, M. G. 2005. Respiratory viral infections in transplant recipients. Curr. Opin. Organ Transplant. 10:312319.
48. Ison, M. G.,, and F. G. Hayden. 2002. Viral infections in immunocompromised patients: what’s new with respiratory viruses? Curr. Opin. Infect. Dis. 15:355367.
49. Jurado, M.,, J. M. Navarro,, J. Hernandez,, M. A. Molina,, and J. M. DePablos. 1995. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant. 15:651652.
50. Kampmann, B.,, D. Cubitt,, T. Walls,, P. Naik,, M. Depala,, S. Samarasinghe,, D. Robson,, A. Hassan,, K. Rao,, H. Gaspar,, G. Davies,, A. Jones,, C. Cale,, K. Gilmour,, M. Real,, M. Foo,, N. Bennett-Rees,, A. Hewitt,, P. Amrolia,, and P. Veys. 2005. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br. J. Haematol. 130:595603.
51. Kawakami, M.,, S. Ueda,, T. Maeda,, T. Karasuno,, H. Teshima,, A. Hiraoka,, H. Nakamura,, K. Tanaka,, and T. Masaoka. 1997. Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 20:485490.
52. Kazory, A.,, S. Singapuri,, A. Wadhwa,, and A. A. Ejaz. 2007. Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir. J. Antimicrob. Chemother. 60:193194.
53. Kitabayashi, A.,, M. Hirokawa,, J. Kuroki,, T. Nishinari,, H. Niitsu,, and A. B. Miura. 1994. Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 14:853854.
54. Krisher, K. K.,, and M. A. Menegus. 1987. Evaluation of three types of cell culture for recovery of adenovirus from clinical specimens. J. Clin. Microbiol. 25:13231324.
55. Kurosaki, K.,, N. Miwa,, Y. Yoshida,, M. Kurokawa,, M. Kurimoto,, S. Endo,, and K. Shiraki. 2004. Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Antivir. Chem. Chemother. 15:281285.
56. Lankester, A. C.,, B. Heemskerk,, E. C. Claas,, M. W. Schilham,, M. F. Beersma,, R. G. Bredius,, M. J. van Tol,, and A. C. Kroes. 2004. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin. Infect. Dis. 38:15211525.
57. La Rosa, A. M.,, R. E. Champlin,, N. Mirza,, J. Gajewski,, S. Giralt,, K. V. Rolston,, I. Raad,, K. Jacobson,, D. Kontoyiannis,, L. Elting,, and E. Whimbey. 2001. Adenovirus infections in adult recipients of blood and marrow transplants. Clin. Infect. Dis. 32:871876.
58. Leen, A. M.,, G. D. Myers,, U. Sili,, M. H. Huls,, H. Weiss,, K. S. Leung,, G. Carrum,, R. A. Krance,, C. C. Chang,, J. J. Molldrem,, A. P. Gee,, M. K. Brenner,, H. E. Heslop,, C. M. Rooney,, and C. M. Bollard. 2006. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat. Med. 12:11601166.
59. Legrand, F.,, D. Berrebi,, N. Houhou,, F. Freymuth,, A. Faye,, M. Duval,, J. F. Mougenot,, M. Peuchmaur,, and E. Vilmer. 2001. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 27:621626.
60. Lehtomaki, K.,, I. Julkunen,, K. Sandelin,, J. Salonen,, M. Virtanen,, M. Ranki,, and T. Hovi. 1986. Rapid diagnosis of respiratory adenovirus infections in young adult men. J. Clin. Microbiol. 24:108111.
61. Leruez-Ville, M.,, V. Minard,, F. Lacaille,, A. Buzyn,, E. Abachin,, S. Blanche,, F. Freymuth,, and C. Rouzioux. 2004. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin. Infect. Dis. 38:4552.
62. Levy, M. F.,, J. S. Crippin,, O. Abbasoglu,, M. Vodapally,, R. M. Goldstein,, B. S. Husberg,, T. A. Gonwa,, and G. B. Klintmalm. 1996. Adenovirus infection of the human intestinal allograft: a case report. Transplant. Proc. 28:27862787.
63. Lewis, P.,, M. Schmidt,, A. Thomas,, P. Cieslak,, L. Grenz,, B. Kendall,, X. Lu,, D. Erdman,, and D. Gilbert. 2007. Adenovirus 14: a new cause of severe community-acquired pneumonia, abstr. LB-5. 2007 Infect. Dis. Soc. Am. Annu. Mtg., San Diego, CA.
64. Lion, T.,, R. Baumgartinger,, F. Watzinger,, S. Matthes-Martin,, M. Suda,, S. Preuner,, B. Futterknecht,, A. Lawitschka,, C. Peters,, U. Potschger,, and H. Gadner. 2003. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102:11141120.
65. Ljungman, P.,, P. Ribaud,, M. Eyrich,, S. Matthes-Martin,, H. Einsele,, M. Bleakley,, M. Machaczka,, M. Bierings,, A. Bosi,, N. Gratecos,, and C. Cordonnier. 2003. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 31:481486.
66. Matsuse, T.,, H. Matsui,, C. Y. Shu,, T. Nagase,, T. Wakabayashi,, S. Mori,, S. Inoue,, Y. Fukuchi,, and H. Orimo. 1994. Adenovirus pulmonary infections identified by PCR and in situ hybridisation in bone marrow transplant recipients. J. Clin. Pathol. 47:973977.
67. McGrath, D.,, M. E. Falagas,, R. Freeman,, R. Rohrer,, R. Fairchild,, C. Colbach,, and D. R. Snydman. 1998. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J. Infect. Dis. 177:459462.
68. McNees, A. L.,, J. A. Mahr,, D. Ornelles,, and L. R. Gooding. 2004. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J. Virol. 78:69556966.
69. Meier, P.,, S. Dautheville-Guibal,, P. M. Ronco,, and J. Rossert. 2002. Cidofovir-induced end-stage renal failure. Nephrol. Dial. Transplant. 17:148149.
70. Mentel, R.,, M. Kinder,, U. Wegner,, M. von Janta-Lipinski,, and E. Matthes. 1997. Inhibitory activity of 3′-fluoro-2′-deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antivir. Res. 34:113119.
71. Mentel, R.,, S. Kurek,, U. Wegner,, M. Janta-Lipinski,, L. Gurtler,, and E. Matthes. 2000. Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level. Med. Microbiol. Immunol. (Berlin) 189:9195.
72. Mentel, R.,, and U. Wegner. 2000. Evaluation of the efficacy of 2′,3′-dideoxycytidine against adenovirus infection in a mouse pneumonia model. Antivir. Res. 47:7987.
73. Michaels, M. G.,, M. Green,, E. R. Wald,, and T. E. Starzl. 1992. Adenovirus infection in pediatric liver transplant recipients. J. Infect. Dis. 165:170174.
74. Miyamura, K.,, M. Hamaguchi,, H. Taji,, T. Kanie,, A. Kohno,, M. Tanimoto,, H. Saito,, S. Kojima,, T. Matsuyama,, K. Kitaori,, K. Nagafuji,, T. Sato,, and Y. Kodera. 2000. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 25:545548.
75. Morfin, F.,, A. Boucher,, F. Najioullah,, Y. Bertrand,, N. Bleyzac,, F. Poitevin-Later,, F. Bienvenu,, V. Simonet,, C. Galambrun,, N. Philippe,, M. Aymard,, D. Thouvenot,, and G. Souillet. 2004. Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients. J. Med. Virol. 72:257262.
76. Morfin, F.,, S. Dupuis-Girod,, S. Mundweiler,, D. Falcon,, D. Carrington,, P. Sedlacek,, M. Bierings,, P. Cetkovsky,, A. C. Kroes,, M. J. van Tol,, and D. Thouvenot. 2005. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir. Ther. 10:225229.
77. Muller, W. J.,, M. J. Levin,, Y. K. Shin,, C. Robinson,, R. Quinones,, J. Malcolm,, E. Hild,, D. Gao,, and R. Giller. 2005. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 41:18121816.
78. Murphy, G. F.,, D. P. Wood, Jr.,, J. W. McRoberts,, and P. J. Henslee-Downey. 1993. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J. Urol. 149:565566.
79. Naesens, L.,, L. Lenaerts,, G. Andrei,, R. Snoeck,, D. Van Beers,, A. Holy,, J. Balzarini,, and E. De Clercq. 2005. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 49:10101016.
80. Nagafuji, K.,, K. Aoki,, H. Henzan,, K. Kato,, T. Miyamoto,, T. Eto,, Y. Nagatoshi,, T. Ohba,, K. Obama,, H. Gondo,, and M. Harada. 2004. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 34:909914.
81. Neofytos, D.,, A. Ojha,, B. Mookerjee,, J. Wagner,, J. Filicko,, A. Ferber,, S. Dessain,, D. Grosso,, J. Brunner,, N. Flomenberg,, and P. Flomenberg. 2007. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol. Blood Marrow Transplant. 13:7481.
82. Neumann, R.,, E. Genersch,, and H. J. Eggers. 1987. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res. 7:9397.
83. Ohori, N. P.,, M. G. Michaels,, R. Jaffe,, P. Williams,, and S. A. Yousem. 1995. Adenovirus pneumonia in lung transplant recipients. Hum. Pathol. 26:10731079.
84. Parizhskaya, M.,, J. Walpusk,, G. Mazariegos,, and R. Jaffe. 2001. Enteric adenovirus infection in pediatric small bowel transplant recipients. Pediatr. Dev. Pathol. 4:122128.
85. Perlman, J.,, C. Gibson,, S. B. Pounds,, Z. Gu,, M. J. Bankowski,, and R. T. Hayden. 2007. Quantitative real-time PCR detection of adenovirus in clinical blood specimens: A comparison of plasma, whole blood and peripheral blood mononuclear cells. J. Clin. Virol. 40:295300.
86. Pinchoff, R. J.,, S. S. Kaufman,, M. S. Magid,, D. D. Erdman,, G. E. Gondolesi,, M. H. Mendelson,, K. Tane,, S. G. Jenkins,, T. M. Fishbein,, and B. C. Herold. 2003. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 76:183189.
87. Polis, M. A.,, K. M. Spooner,, B. F. Baird,, J. F. Manischewitz,, H. S. Jaffe,, P. E. Fisher,, J. Falloon,, R. T. Davey, Jr.,, J. A. Kovacs,, R. E. Walker,, S. M. Whitcup,, R. B. Nussenblatt,, H. C. Lane,, and H. Masur. 1995. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39:882886.
88. Potter, C. W.,, J. P. Phair,, L. Vodinelich,, R. Fenton,, and R. Jennings. 1976. Antiviral, immunosuppressive and antitumour effects of ribavirin. Nature 259:496497.
89. Rabalais, G. P.,, G. G. Stout,, K. L. Ladd,, and K. M. Cost. 1992. Rapid diagnosis of respiratory viral infections by using a shell vial assay and monoclonal antibody pool. J. Clin. Microbiol. 30:15051508.
90. Raboni, S. M.,, M. M. Siqueira,, S. R. Portes,, and R. Pasquini. 2003. Comparison of PCR, enzyme immunoassay and conventional culture for adenovirus detection in bone marrow transplant patients with hemorrhagic cystitis. J. Clin. Virol. 27:270275.
91. Raty, R.,, M. Kleemola,, K. Melen,, M. Stenvik,, and I. Julkunen. 1999. Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections. J. Med. Virol. 59:6672.
92. Rector, A.,, N. Azzi,, C. Liesnard,, K. Zlateva,, D. Van Beers,, R. Snoeck,, and M. Van Ranst. 2002. Use of polymerase chain reaction for diagnosis of disseminated adenovirus infection. Pediatr. Infect. Dis. J. 21:11761178.
93. Regn, S.,, S. Raffegerst,, X. Chen,, D. Schendel,, H. J. Kolb,, and M. Roskrow. 2001. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant. 27:5364.
94. Robinson, C.,, and M. Echavarria. 2007. Adenoviruses, p. 1589–1600. In P. R. Murray,, E. J. Baron,, J. H. Jorgensen,, M. L. Landry, and, M. A. Pfaller (ed.), Manual of Clinical Microbiology, 9th ed., vol. 2. ASM Press, Washington, DC.
95. Runde, V.,, S. Ross,, R. Trenschel,, E. Lagemann,, O. Basu,, K. Renzing-Kohler,, U. W. Schaefer,, M. Roggendorf,, and E. Holler. 2001. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant. 28:5157.
96. Russell, K. L.,, M. P. Broderick,, S. E. Franklin,, L. B. Blyn,, N. E. Freed,, E. Moradi,, D. J. Ecker,, P. E. Kammerer,, M. A. Osuna,, A. E. Kajon,, C. B. Morn,, and M. A. K. Ryan. 2006. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J. Infect. Dis. 194:877885.
97. Rux, J. J.,, P. R. Kuser,, and R. M. Burnett. 2003. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J. Virol. 77:95539566.
98. Sabroe, I.,, J. McHale,, D. R. Tait,, W. A. Lynn,, K. N. Ward,, and S. Shaunak. 1995. Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. Thorax 50:12191220.
99. Schilham, M. W.,, E. C. Claas,, W. van Zaane,, B. Heemskerk,, J. M. Vossen,, A. C. Lankester,, R. E. Toes,, M. Echavarria,, A. C. Kroes,, and M. J. van Tol. 2002. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis. 35:526532.
100. Scott-Taylor, T. H.,, and G. W. Hammond. 1992. Conserved sequences of the adenovirus genome for detection of all human adenovirus types by hybridization. J. Clin. Microbiol. 30:17031710.
101. Seidemann, K.,, A. Heim,, E. D. Pfister,, H. Koditz,, A. Beilken,, A. Sander,, M. Melter,, K. W. Sykora,, M. Sasse,, and A. Wessel. 2004. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am. J. Transplant. 4:21022108.
102. Sharp, I. R.,, and G. Wadell. 2007. Adenoviruses, p. 287–308. In A. J. Zuckerman,, J. E. Banatvala, and, J. R. Pattison (ed.), Principles and Practice of Clinical Virology, 3rd ed. John Wiley and Sons, New York, NY.
103. Shields, A. F.,, R. C. Hackman,, K. H. Fife,, L. Corey,, and J. D. Meyers. 1985. Adenovirus infections in patients undergoing bone-marrow transplantation. N. Engl. J. Med. 312:529533.
104. Shirali, G. S.,, J. Ni,, R. E. Chinnock,, J. K. Johnston,, G. L. Rosenthal,, N. E. Bowles,, and J. A. Towbin. 2001. Association of viral genome with graft loss in children after cardiac transplantation. N. Engl. J. Med. 344:14981503.
105. Smith, C. A.,, L. S. Woodruff,, G. R. Kitchingman,, and C. M. Rooney. 1996. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J. Virol. 70:67336740.
106. Smith, K. O.,, K. S. Galloway,, W. L. Kennell,, K. K. Ogilvie,, and B. K. Radatus. 1982. A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 22:5561.
107. Takiff, H. E.,, and S. E. Straus. 1982. Early replicative block prevents the efficient growth of fastidious diarrhea-associated adenoviruses in cell culture. J. Med. Virol. 9:93100.
108. Takiff, H. E.,, S. E. Straus,, and C. F. Garon. 1981. Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells. Lancet ii:832834.
109. Tate, J.,, M. Widdowson,, L. Anderson,, L. Lott,, X. Lu,, and M. Bunning. 2007. Adenovirus 14 infection in basic military trainees, abstr. LB-14. 2007 Annu. Mtg. Infect. Dis. Soc. Am., San Diego, CA.
110. Trousdale, M. D.,, P. L. Goldschmidt,, and R. Nobrega. 1994. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea 13:435439.
111. Van Doornum, G. J.,, and J. C. De Jong. 1998. Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method. J. Clin. Microbiol. 36:28652868.
112. van Tol, M. J.,, A. C. Kroes,, J. Schinkel,, W. Dinkelaar,, E. C. Claas,, C. M. Jol-van der Zijde,, and J. M. Vossen. 2005. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 36:3950.
113. Vittecoq, D.,, L. Dumitrescu,, H. Beaufils,, and G. Deray. 1997. Fanconi syndrome associated with cidofovir therapy. Antimicrob. Agents. Chemother. 41:1846.
114. Walls, T.,, K. Hawrami,, I. Ushiro-Lumb,, D. Shingadia,, V. Saha,, and A. G. Shankar. 2005. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin. Infect. Dis. 40:12441249.
115. Waring, G. E.,, P. R. Laibson,, J. E. Satz,, and N. H. Joseph. 1976. Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19. Am. J. Ophthalmol. 82:781785.
116. Wold, W. S. M.,, and M. S. Horwitz. 2007. Adenoviruses, p. 2395–2436. In D. M. Knipe and, P. M. Howley (ed.), Fields Virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
117. Wreghitt, T. G.,, J. J. Gray,, K. N. Ward,, A. Salt,, D. L. Taylor,, N. J. Alp,, and A. S. Tyms. 1989. Disseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovir. J. Infect. 19:8889.
118. Yusuf, U.,, G. A. Hale,, J. Carr,, Z. Gu,, E. Benaim,, P. Woodard,, K. A. Kasow,, E. M. Horwitz,, W. Leung,, D. K. Srivastava,, R. Handgretinger,, and R. T. Hayden. 2006. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81:13981404.
119. Zheng, X.,, X. Lu,, D. D. Erdman,, E. J. Anderson,, J. A. Guzman-Cottrill,, M. Kletzel,, and B. Z. Katz. 2008. Identification of adenoviruses from high-risk pediatric stem cell transplant recipients and controls. J. Clin. Microbiol. 46:317320.

Tables

Generic image for table
Table 1.

Infections associated with ADV species and serotypes

Citation: Anderson E, Ison M. 2008. Adenoviral Infections in Transplant Recipients, p 75-91. In Scheld W, Hammer S, Hughes J (ed), Emerging Infections 8. ASM Press, Washington, DC. doi: 10.1128/9781555815592.ch5
Generic image for table
Table 2.

Available agents with activity against ADV

Citation: Anderson E, Ison M. 2008. Adenoviral Infections in Transplant Recipients, p 75-91. In Scheld W, Hammer S, Hughes J (ed), Emerging Infections 8. ASM Press, Washington, DC. doi: 10.1128/9781555815592.ch5

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error